Uroplasty Announces Implanted Tibial Nerve Stimulator Long-Term Study Presentation at International Continence Society (via PR Newswire)
MINNETONKA, Minn., Oct. 15, 2012 /PRNewswire/ — Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of a long-term clinical pilot study using an implantable…
